全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Hartwig Huland , Pierre Tennstedt ...
来源:[J].Strahlentherapie und Onkologie(IF 4.163), 2017, Vol.193 (9), pp.692-699Springer
摘要:The optimal prostate-specific antigen (PSA) level after radical prostatectomy (RP) for defining biochemical recurrence and initiating salvage radiation therapy (SRT) is still debatable. Whereas adjuvant or extremely early SRT irrespective of PSA progression might be overtreatment...
作者:... Markus Graefen , Hartwig Huland , Derya Tilki
来源:[J].World Journal of Urology(IF 2.888), 2017, Vol.35 (12), pp.1833-1839Springer
摘要:This study aimed at analysing long-term oncologic outcomes in prostate cancer patients with limited nodal disease (1–2 positive lymph nodes) without adjuvant therapy after radical prostatectomy (RP).
作者:Hartwig Huland , Guido Sauter ...
来源:[J].BMC Cancer(IF 3.333), 2016, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)TMPRSS2:ERG fusions are frequent in prostate cancer, and occur predominantly in young patients. Several studies had proposed intratumoral heterogeneity of these fusions. This study was designed to determine frequency and extent of ERG fusion hete...
作者:Hartwig Huland , Markus Graefen ...
来源:[J].BMC Cancer(IF 3.333), 2018, Vol.18 (1), pp.1-9DOAJ
摘要:Abstract Background Prostate Stem Cell Antigen (PSCA) is frequently expressed in prostate cancer but its exact function is unclear. Methods To clarify contradictory findings on the prognostic role of PSCA expression, a tissue microarray containing 13,665 prostate cancers was anal...
作者:Hartwig Huland , Ronald Simon ...
来源:[J].International Journal of Molecular Sciences(IF 2.464), 2015, Vol.16 (4), pp.8591-8606DOAJ
摘要:The VEGFR-1 is suggested to promote tumor progression. In the current study we analyzed prevalence and prognostic impact of the VEGFR-1 by immunohistochemistry on a tissue microarray containing more than 3000 prostate cancer specimens. Results were compared to tumor phenotype, ET...
作者:... Thorsten Schlomm , Hartwig Huland , Udo Schumacher
来源:[J].Scientific Reports(IF 2.927), 2018, Vol.8 (1), pp.1-11DOAJ
摘要:Abstract Here we describe the establishment and characterization of an AR+, PSMA+, ERG+, PTEN−/−, CHD1+/− patient-derived xenograft (PDX model termed ‘C5’, which has been developed from a 60 years old patient suffering from castration-resistant prostate cancer (CRP...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×